Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alcidion GroupASX:ALC +1.04% Days Sales Outstanding is 98.65 as of Jun. 2026, which is 112% above its 10-year median of 46.60. The stock has 4 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Alcidion Group ranks worse than 65.81% on this metric.
Alcidion Group's average Accounts Receivable for the
six
months ended in Jun. 2026 was A$8.83 Mil. Alcidion Group's Revenue for the
six
months ended in Jun. 2026 was A$16.34 Mil.
Hence, Alcidion Group's Days Sales Outstanding for the
six
months ended in Jun. 2026 was 98.65.
The historical rank and industry rank for Alcidion Group's Days Sales Outstanding or its related term are showing as below:
ASX:ALC'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.74 Med: 46.6 Max: 181.81
Current: 62.11
During the past 13 years, Alcidion Group's highest Days Sales Outstanding was 181.81. The lowest was 33.74. And the median was 46.60.
ASX:ALC's Days Sales Outstanding is ranked worse than 65.81% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 45.74
vs ASX:ALC: 62.11
Alcidion Group's Days Sales Outstanding
increased
from Jun. 2025 (83.38) to Jun. 2026 (98.65).
Alcidion Group (ASX:ALC) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Alcidion Group Days Sales Outstanding Related Terms
Alcidion Group Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Alcidion Group's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ALC vs VEEV, BTSG, HQY: Days Sales Outstanding Comparison
For the Health Information Services subindustry, Alcidion Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Alcidion Group's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group (ASX:ALC) has a Days Sales Outstanding of 98.65 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Alcidion Group and its competitors. This is 112% above median its historical median of 46.60. Over the past decade, Alcidion Group's Days Sales Outstanding has ranged from 33.74 to 181.81. According to the industry distribution chart, Alcidion Group ranks #435 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 65.8%.
Is Alcidion Group's Days Sales Outstanding too high?
Alcidion Group's current Days Sales Outstanding of 98.65 is 112% above median its 10-year median of 46.60. Over the past 10 years, this metric has ranged from a low of 33.74 to a high of 181.81. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.74. Alcidion Group's value of 98.65 is 115.7% above this industry median. Based on the distribution chart, Alcidion Group ranks #435 out of 661 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Alcidion Group's Days Sales Outstanding compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #435 out of 661 companies for Days Sales Outstanding. This places Alcidion Group in the lower half of its industry. The industry median Days Sales Outstanding is 45.74. Alcidion Group's value of 98.65 is 115.7% above this benchmark. Historically, Alcidion Group's own Days Sales Outstanding has ranged from 33.74 to 181.81 over the past decade. While the company's 10-year median is 46.60 vs. the industry median of 45.74, Alcidion Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.74, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current Days Sales Outstanding of 98.65 is 115.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Days Sales Outstanding is 98.65, which is 112% above median its own 10-year median of 46.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Fairly Valued. The stock's GF Value™ is A$0.10, compared to a current price of A$0.10 — trading 3% below its estimated fair value. The current Days Sales Outstanding is 98.65, which is 112% above median its 10-year median of 46.60 and 115.7% above the Healthcare Providers & Services industry median of 45.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Days Sales Outstanding is 98.65 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 
